Clinical Trials Logo
  1. Home
  2. Immune System
  3. NCT06312423

Safety and Pharmacokinetics of IMT504, an Immunomodulator and Tissue Repair Inducer — ECDA000/02  

Immune System Clinical Trial

Official title:
Phase 1 Open-label Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of IMT504 Phosphorothioate Oligonucleotide, an Immunomodulator and Tissue Repair Inducer, in Healthy Volunteers

Clinical Trial Summary

Phase 1 open-label dose-escalation study to evaluate the safety and pharmacokinetics of IMT504 Phosphorothioate Oligonucleotide, an immunomodulator and tissue repair inducer, in healthy volunteers.

Clinical Trial Description

This is a phase 1 open-label dose-escalation study to evaluate the safety and pharmacokinetics of IMT504 Phosphorothioate Oligonucleotide, an immunomodulator and tissue repair inducer, in healthy volunteers. A total of 12 adult volunteers of both sexes will be included, who will be progressively incorporated into 3 groups of 4 volunteers each. The first group will be administered subcutaneously with a single dose of 20 mg of IMT504. The second group will receive 3 doses (20 mg daily for 3 days) and then, if no toxicity is detected, the last group will be administered 5 daily doses of 20 mg/d. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06312423
Study type Interventional
Source Ministry of Public Health of the Province of La Rioja
Contact Ricardo A Lopez, Doctor
Phone 5491133016577
Email ralopez.new@gmail.com
Status Recruiting
Phase Phase 1
Start date February 23, 2024
Completion date December 30, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT02277080 - The Immune and Endocrine Systems in Chronic Non-cancer Patients Treated With Opioids
Active, not recruiting NCT05026242 - Effects of Almond Consumption on Innate and Adaptive Immune System N/A
Completed NCT04701502 - Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19 Phase 2
Terminated NCT05133128 - An Experimental Medicine Clinical Study to Compare Peripheral Immune System From Subjects Without Cancer Diagnosis and Patients With Solid Tumours. N/A
Recruiting NCT05792137 - Postprandial Monocyte Study N/A
Completed NCT05329337 - Link Between the Peripheral Mononuclear Cells' Capacity to Induce Insulin Resistance and Hyperinsulinemia N/A
Completed NCT06263686 - Evaluation of the Effects of Routine Intake of Fresh vs- Pasteurized Yoghurt on the Immune System in Healthy Adults N/A
Recruiting NCT04772794 - Immunologic Effect of Fraction of Inspired Oxygen N/A
Completed NCT00753402 - The Effects of Epinephrine in Endotoxemia in Normal Volunteers Phase 1
Completed NCT00820989 - Inflammation and the Host Response to Injury (In Healthy Volunteers) Phase 1
Completed NCT05221996 - Minimal-Dose Resistance Training for Improving sIgA and Cortisol N/A
Completed NCT04275440 - Effects of Caloric Restriction and Exercise on Body Weight, Immune Function, and Intestinal Flora N/A
Recruiting NCT06109337 - Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder
Recruiting NCT05648136 - Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage N/A
Completed NCT06190379 - Aromatherapy for Upper Respiratory Health N/A
Recruiting NCT05334888 - Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach
Completed NCT00730626 - Dose Response Study of a Fermented Yogurt on the Immune System and Gut Health N/A
Recruiting NCT06400212 - CytoHealth - A Study of the Inflammatory Response to Exercise N/A